Also trades as: 4523.T (JPX) · $vol 49M · ESALY (OTC) · $vol 2M · ESALF (OTC) · $vol 0M

$7.41

-0.22 (-2.88%)

Weekly Expected Move ±4.3%

$7 $7 $7 $8 $8

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 58 · $8.4B mcap · 281M float · 0.062% daily turnover · Short 85% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$789.4B +6.4% ▲

5Y CAGR: +2.6%

Gross Profit

$620.6B +5.8% ▲

5Y CAGR: +3.6%

Operating Income

$54.4B +1.8% ▲

5Y CAGR: -15.4%

Net Income

$46.4B +9.5% ▲

5Y CAGR: -17.5%

EPS (Diluted)

$40.94 +10.8% ▲

5Y CAGR: -17.4%

EBITDA

$104.5B +1.3% ▲

5Y CAGR: -8.5%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$645.9B	$756.2B	$744.4B	$741.8B	$789.4B
YoY Growth	-7.1%	+17.1%	-1.6%	-0.4%	+6.4%
Cost of Revenue	$161.3B	$174.8B	$177.8B	$155.3B	$168.8B
Gross Profit	$484.6B	$581.4B	$566.6B	$586.4B	$620.6B
Gross Margin	75.0%	76.9%	76.1%	79.1%	78.6%
R&D Expenses	$150.3B	$171.7B	$173.0B	$169.0B	$171.6B
SG&A Expenses	$281.4B	$366.4B	$358.3B	$364.1B	$408.0B
Operating Expenses	$432.9B	$527.6B	$526.5B	$532.8B	$566.2B
Operating Income	$53.2B	$53.8B	$40.0B	$53.4B	$54.4B
Operating Margin	8.2%	7.1%	5.4%	7.2%	6.9%
Interest Expense	$1.4B	$1.7B	$2.3B	$2.4B	$3.5B
Income Before Tax	$52.6B	$54.5B	$45.0B	$61.8B	$61.1B
Tax Expense	$10.1B	$8.7B	-$11.8B	$18.0B	$13.0B
Net Income	$41.9B	$48.0B	$55.4B	$42.4B	$46.4B
Net Margin	6.5%	6.3%	7.4%	5.7%	5.9%
EPS (Diluted)	$36.73	$41.81	$48.33	$36.97	$40.94
EBITDA	$89.5B	$94.6B	$87.3B	$103.1B	$104.5B
Shares Outstanding	1.15B	1.15B	1.15B	1.15B	1.13B

Line Item	FY2024 Q1	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$189.0B	$1.4B	$1.2B	$1.4B	$1.3B	$223.9B	$209.2B	$237.4B
Cost of Revenue	$39.8B	$301M	$266M	$295M	$309M	$52.0B	$53.0B	$51.8B
Gross Profit	$149.3B	$1.1B	$969M	$1.1B	$1.0B	$171.9B	$156.2B	$185.7B
Gross Margin	79.0%	78.7%	78.4%	79.0%	76.9%	76.8%	74.7%	78.2%
R&D Expenses	$41.7B	$286M	$304M	$268M	$249M	$39.9B	$44.7B	$44.3B
SG&A Expenses	$99.5B	$686M	$699M	$693M	$704M	$113.7B	$121.7B	$116.3B
Operating Expenses	$135.9B	$972M	$1.0B	$962M	$953M	$153.6B	$166.5B	$160.6B
Operating Income	$13.4B	$145M	-$34M	$146M	$76M	$18.3B	-$10.2B	$25.0B
Operating Margin	7.1%	10.2%	-2.8%	10.4%	5.7%	8.2%	-4.9%	10.5%
Interest Expense	$715M	$5M	$7M	$6M	$10M	$1.5B	$1.6B	$2.0B
Income Before Tax	$16.0B	$194M	-$138K	$155M	$99M	$22.4B	-$8.1B	$25.6B
Tax Expense	$4.5B	$34M	-$4M	$49M	$27M	$4.2B	-$4.8B	$6.2B
Net Income	$10.6B	$156M	$6M	$100M	$69M	$17.5B	-$3.3B	$18.5B
Net Margin	5.6%	11.0%	0.5%	7.1%	5.1%	7.8%	-1.6%	7.8%
EPS (Diluted)	$9.24	$0.14	$0.01	$0.09	$0.02	$15.50	$-2.94	$16.15
EBITDA	$26.7B	$265M	$72M	$228M	$175M	$34.1B	-$86M	$34.6B
Shares Outstanding	1.15B	1.13B	1.13B	1.13B	1.13B	1.13B	1.13B	1.13B

ESAIY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet